Livongo, a Mountain View, Calif.-based diabetes management startup, raised an additional $52.5 million in funding, according to Chicago Inno.
Livongo — led by CEO Glen Tullman, former CEO of Allscripts — offers a blood glucose monitor, which connects to a digital dashboard for real-time health information. Its goal is to help diabetes patients manage their care.
This most recent funding round was co-led by General Catalyst and Kinnevik. Other investors included Singapore-based EDBI, American Investment Holdings and Microsoft Ventures.
The startup, which has raised more than $143 million since its launch in 2014, plans to expand into other chronic condition management services with this new funding. It will also begin distribution into international markets.